Bigul

Laurus Labs Ltd - 540222 - Closure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company shall remain closed from April 01, 2022 till 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2022. The date of Board Meeting of the Company for consideration and approval of the audited financial results for the quarter and year ended March 31, 2022 will be intimated later.
30-03-2022

Buy Laurus Labs: target of Rs 735: Sharekhan

Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 735 in its research report dated March 25, 2022.
28-03-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Further to our letter dated March 11, 2022 regarding intimation of Schedule of Analyst/ Institutional Investor meeting on March 15-16, 2022, please find enclosed the Presentation which would be discussed during the meeting.
14-03-2022

Laurus Labs surges 6% to hit over 4-month high

Analysts remain optimistic on the company's outlook for FY23 & FY24 with new capacity addition for commercial usage for FDF and API segments, ARV business and robust growth expected in CS business.
11-03-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst/ Institutional Investor Meetings
11-03-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst/ Institutional Investor Meetings
21-02-2022

Laurus Labs up 8% in two days on purchase orders from global pharma company

The company on Thursday said it has received purchase orders from a leading global life sciences company and the supplies will commence from March 2022.
11-02-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

we hereby inform you that the Company received purchase orders from a leading Global Life Sciences Company and the supplies will commence from Mar 2022. Please note that execution of these orders are subject to fulfilment of certain performance obligations
10-02-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst/ Institutional Investor Meetings
07-02-2022
Bigul

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Q3 FY22 Earnings call transcript for the call held on January 28, 2022
02-02-2022
Next Page
Close

Let's Open Free Demat Account